Clinical Trial Update: To Evaluate the Efficacy and Safety of Inhaled Corticosteroids Combined With Bronchodilators and Programmed Death-ligand 1 (PD-L1) Inhibitor Plus Platinum-based Chemotherapy in Patients With Advanced Lung Squamous Cell Carcinoma Complicated With Chronic Obstructive Pulmonary Disease (COPD)

View source ↗

Summary

A clinical trial is evaluating whether adding inhaled corticosteroids and bronchodilators to a PD-L1 inhibitor plus platinum-based chemotherapy improves outcome…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• Bronchodilators
• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Inhaled corticosteroids (corticosteroid, inhaled)
• PD-L1 inhibitor (Programmed death-ligand 1 inhibitor)

Snippet

Sponsor: Guangzhou Institute of Respiratory Disease | Conditions: Lung Cancer Squamous Cell, COPD | Status: RECRUITING